Dare Bioscience, Inc. Increase (Decrease) in Prepaid Expense
Dare Bioscience, Inc. (DARE) reported Increase (Decrease) in Prepaid Expense of $1.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-13
- Dare Bioscience, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was $1.01M, a 393.66% increase year-over-year.
- Dare Bioscience, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $378.47K.
- Dare Bioscience, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$114.23K.
- Dare Bioscience, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was -$84.51K.
- Dare Bioscience, Inc. increase (decrease) in prepaid expense for fiscal 2025 was -$668.49K.
- Dare Bioscience, Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$3.60M.
- Dare Bioscience, Inc. increase (decrease) in prepaid expense for fiscal 2023 was -$547.71K, a 113.07% decline from fiscal 2022.
- Dare Bioscience, Inc. increase (decrease) in prepaid expense for fiscal 2022 was $4.19M, a 573.17% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 7 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.38M 10-Q · filed 2026-08-13 | $1.27M derived: sum of 3 quarters · filed 2026-08-13 | $1.19M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $378.47K 10-Q · filed 2026-05-14 | $264.24K derived: sum of 2 quarters · filed 2026-05-14 | $179.74K derived: sum of 3 quarters · filed 2026-05-14 | $383.50K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$114.23K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$198.74K derived: sum of 2 quarters · filed 2026-03-26 | $5.02K derived: sum of 3 quarters · filed 2026-08-13 | -$668.49K 10-K · filed 2026-03-26 | |
| 2025-09-30 | -$84.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $119.25K derived: sum of 2 quarters · filed 2026-08-13 | -$554.26K 10-Q · filed 2025-11-13 | -$1.23M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $203.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$469.75K 10-Q · filed 2026-08-13 | -$1.14M derived: sum of 3 quarters · filed 2026-08-13 | -$1.46M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$673.51K 10-Q · filed 2026-05-14 | -$1.35M derived: sum of 2 quarters · filed 2026-05-14 | -$1.67M derived: sum of 3 quarters · filed 2026-05-14 | -$2.97M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$675.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$992.58K derived: sum of 2 quarters · filed 2026-03-26 | -$2.29M derived: sum of 3 quarters · filed 2026-03-26 | -$3.60M 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$317.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.62M derived: sum of 2 quarters · filed 2025-11-13 | -$2.92M 10-Q · filed 2025-11-13 | -$3.39M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.61M 10-Q · filed 2025-08-14 | -$3.07M derived: sum of 3 quarters · filed 2025-08-14 | -$4.56M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$1.30M 10-Q · filed 2025-05-13 | -$1.77M derived: sum of 2 quarters · filed 2025-05-13 | -$3.26M derived: sum of 3 quarters · filed 2025-05-13 | -$2.27M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$461.66K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.95M derived: sum of 2 quarters · filed 2025-03-31 | -$964.18K derived: sum of 3 quarters · filed 2025-03-31 | -$547.71K 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$502.52K derived: sum of 2 quarters · filed 2024-11-14 | -$86.05K 10-Q · filed 2024-11-14 | -$305.56K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $987.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.40M 10-Q · filed 2024-08-12 | $1.18M derived: sum of 3 quarters · filed 2024-08-12 | $2.17M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $416.46K 10-Q · filed 2024-05-14 | $196.95K derived: sum of 2 quarters · filed 2024-05-14 | $1.18M derived: sum of 3 quarters · filed 2024-05-14 | $312.03K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$219.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $761.62K derived: sum of 2 quarters · filed 2024-03-28 | -$104.44K derived: sum of 3 quarters · filed 2024-03-28 | $4.19M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $981.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $115.07K derived: sum of 2 quarters · filed 2023-11-09 | $4.41M 10-Q · filed 2023-11-09 | $4.37M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$866.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $3.43M 10-Q · filed 2023-08-10 | $3.39M derived: sum of 3 quarters · filed 2023-08-10 | $3.91M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $4.29M 10-Q · filed 2023-05-11 | $4.25M derived: sum of 2 quarters · filed 2023-05-11 | $4.78M derived: sum of 3 quarters · filed 2023-05-11 | $5.13M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$39.51K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $484.56K derived: sum of 2 quarters · filed 2023-03-30 | $839.52K derived: sum of 3 quarters · filed 2023-03-30 | $622.34K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $524.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $879.04K derived: sum of 2 quarters · filed 2022-11-10 | $661.85K 10-Q · filed 2022-11-10 | $1.13M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $354.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $137.78K 10-Q · filed 2022-08-09 | $610.59K derived: sum of 3 quarters · filed 2022-08-09 | -$552.34K derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | -$217.19K 10-Q · filed 2022-05-12 | $255.63K derived: sum of 2 quarters · filed 2022-05-12 | -$907.30K derived: sum of 3 quarters · filed 2022-05-12 | -$2.50M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $472.81K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$690.11K derived: sum of 2 quarters · filed 2022-03-31 | -$2.28M derived: sum of 3 quarters · filed 2022-03-31 | $454.13K 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$2.75M derived: sum of 2 quarters · filed 2021-11-10 | -$18.68K 10-Q · filed 2021-11-10 | -$63.61K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.14M 10-Q · filed 2021-08-12 | $1.10M derived: sum of 3 quarters · filed 2021-08-12 | $1.43M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $2.74M 10-Q · filed 2021-05-13 | $2.69M derived: sum of 2 quarters · filed 2021-05-13 | $3.02M derived: sum of 3 quarters · filed 2021-05-13 | $2.86M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | -$44.93K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $287.62K derived: sum of 2 quarters · filed 2021-03-30 | $121.35K derived: sum of 3 quarters · filed 2021-03-30 | $322.48K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $332.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $166.28K derived: sum of 2 quarters · filed 2020-11-12 | $367.41K 10-Q · filed 2020-11-12 | $220.56K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | -$166.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $34.86K 10-Q · filed 2020-08-12 | -$111.99K derived: sum of 3 quarters · filed 2020-08-12 | $90.55K derived: sum of 4 quarters · filed 2020-08-12 | |
| 2019-03-31 | $201.13K 10-Q · filed 2020-05-14 | $54.28K derived: sum of 2 quarters · filed 2020-05-14 | $256.82K derived: sum of 3 quarters · filed 2020-05-14 | $313.35K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$146.85K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $55.69K derived: sum of 2 quarters · filed 2020-03-27 | $112.22K derived: sum of 3 quarters · filed 2020-03-27 | $91.53K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $202.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $259.07K derived: sum of 2 quarters · filed 2019-11-12 | $238.38K 10-Q · filed 2019-11-12 | $126.97K derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $56.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $35.84K 10-Q · filed 2019-08-14 | -$75.57K derived: sum of 3 quarters · filed 2019-08-14 | ||
| 2018-03-31 | -$20.69K 10-Q · filed 2019-05-14 | -$132.11K derived: sum of 2 quarters · filed 2019-05-14 | |||
| 2017-12-31 | -$111.41K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $113.02K 10-K · filed 2019-04-01 | |||
| 2017-09-30 | $224.43K 10-Q · filed 2018-11-13 | ||||
| 2016-12-31 | -$250.00K 10-K · filed 2018-03-28 | ||||
| 2016-06-30 | -$250.00K 8-K/A · filed 2017-10-02 | ||||
| 2015-12-31 | $250.00K 8-K/A · filed 2017-10-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |